BioCina
Adelaide, Australia
Program data pending ClinicalTrials.gov matching
—
Not Assessed
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, LNP, Plasmid DNA, Microbial Biologics, Sterile Injectables, Fill-Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press10 articles
Broad modality coverage (6 modalities)
Recent News 10 articles
Australia's BioCina and NovaCina merger bolsters global CDMO industry - BioSpectrum Asia
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine - The Malaysian Reserve
BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA cGMP manufacturing - PR Newswire
BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer - PR Newswire
EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment - PR Newswire
BioCina and NovaCina merger aims to bolster the global CDMO industry - Biotech Dispatch
BioCina and NovaCina Merger Bolsters Global CDMO Industry - PR Newswire
BioCina expands into full-service CDMO with full control of Pfizer manufacturing facility in Adelaide, Australia - PR Newswire
Cytiva supports BioCina with first GMP facility for mRNA in Australia - Cleanroom Technology
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx - PR Newswire
Represent this organization? Contact us to verify or update this profile.